1146P Updated results from POD1UM-201: A phase II study of retifanlimab in patients with advanced or metastatic Merkel cell carcinoma (MCC)
Giovanni Grignani, Piotr Rutkowski, Célèste Lebbé, Michele Guida, C. Gaudy Marqueste, Filippo de Braud, Francesco Spagnolo, Melissa Burgess, Henri Montaudié, Roberta Depenni, Francesca Spada, Jennifer Pulini, Mark Cornfeld, Chuan Tian, Shailender Bhatia
Topics & Concepts
MedicineInternal medicineMerkel cell carcinomaClinical endpointOncologyResponse Evaluation Criteria in Solid TumorsProgressive diseaseChemotherapyCohortSurgeryClinical trialCarcinomaPolyomavirus and related diseasesBacteriophages and microbial interactionsPlant Virus Research Studies